Polyamine biosynthesis as a target to inhibit apoptosis of non-tumoral cells

F. Flamigni, I. Stanic', A. Facchini, S. Cetrullo, B. Tantini, R. M. Borzì, C. Guarnieri, C. M. Caldarera

Research output: Contribution to journalArticlepeer-review


Growing evidence suggests a role for polyamines in apoptosis, although the relationship appears to be complex. α-Difluoromethylornithine (DFMO), a largely used ornithine decarboxylase inhibitor, is cytostatic, hardly cytotoxic and may even increase the resistance of tumour cells to some apoptotic stimuli. This may represent a problem in cancer therapy, where the killing of tumoral cells would be a desired effect, but could be an advantage in other pathological contexts related to an excess of apoptosis, such as cardiovascular diseases, stem cell transplantation, arthritis and infections. In different cellular models, polyamine depletion following treatment with polyamine biosynthesis inhibitors appears to inhibit mitochondrial and death receptor pathways of apoptosis by affecting key proteins. These studies indicate that inhibition of polyamine biosynthesis may prevent or reduce the apoptotic response triggered by a variety of stimuli in non-tumoral cells, such as cardiac cells, stem cells, chondrocytes, macrophages and intestinal epithelial cells.

Original languageEnglish
Pages (from-to)197-202
Number of pages6
JournalAmino Acids
Issue number2
Publication statusPublished - Aug 2007


  • Apoptosis
  • Caspases
  • Difluoromethylornithine
  • Non-tumoral cells
  • Polyamines
  • Signal transduction

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology


Dive into the research topics of 'Polyamine biosynthesis as a target to inhibit apoptosis of non-tumoral cells'. Together they form a unique fingerprint.

Cite this